Edan Instruments

Edan Instruments Grahami arv

Grahami arv ettevõttest Edan Instruments (300206.SZ) seisuga 22. okt 2026 on 6,70 CNY. Eelmisel aastal oli Grahami arv 4,67 CNY — muutus 43,43% (kõrgem).

Grahami arv

6,70CNY

YoY

43,43%

Viimati uuendatud:

Grahami arv ettevõttest Edan Instruments on 2025 6,70 CNY. Grahami arv ettevõttest Edan Instruments oli 2024 4,67 CNY. See väheneb 43,43% kõrgem võrreldes eelmise aastaga.

Edan Instruments Grahami arv ajalugu

  • 3 aastat

  • 10 aastat

  • 25 aastat

  • Max

Grahami arv
Kuupäev
Grahami arv
1. jaan 2018
2,77 CNY
1. jaan 2019
3,37 CNY
1. jaan 2020
8,88 CNY
1. jaan 2021
5,18 CNY
1. jaan 2022
5,40 CNY
1. jaan 2023
5,40 CNY
1. jaan 2024
4,67 CNY
1. jaan 2025
6,70 CNY
Edan Instruments Grahami arv ajalugu
AASTAGrahami arvYoY
6,70CNY+43,43%
4,67CNY−13,50%
5,40CNY−0,04%
5,40CNY+4,31%
5,18CNY−41,73%
8,88CNY+163,83%
3,37CNY+21,65%
2,77CNY+46,31%
1,89CNY+30,81%
1,45CNY−49,25%
2,85CNY+170,07%
1,06CNY—

Hangi need andmed Eulerpool API kaudu

100 000 päringut/kuus tasuta · krediitkaarti pole

Edan Instruments Aktsiate analüüs

Mida Edan Instruments teeb? Edan Instruments, Inc. generates revenue through the design, manufacture, and sale of medical equipment, including maternity product series like doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors, and maternity integrated diagnostic monitoring systems. The company also sells electrocardiograph series such as digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, and electrocardiographic workstations, along with monitoring products like portable multi-variable monitors and central monitoring systems. Additionally, Edan offers spare parts and in vitro diagnostics products to support its equipment and medical services. The primary buyers of Edan's products are healthcare institutions, including hospitals and clinics, which purchase medical devices for diagnostic and monitoring purposes. These institutions rely on Edan's maternity, electrocardiograph, and monitoring systems to provide patient care. The company's in vitro diagnostics products are also sold to medical facilities for laboratory testing needs. Edan's product segments are defined by medical equipment categories: maternity, electrocardiograph, monitoring, and ultrasonic image systems. The spare parts and in vitro diagnostics businesses complement these segments by providing essential accessories and diagnostic tools. Revenue is derived from direct sales of these products to healthcare providers, with no mention of third-party distribution or additional services beyond the described offerings. Edan Instruments on üks populaarsemaid ettevõtteid Eulpoolist.

Sageli esitatud küsimused Edan Instruments aktsia kohta

Edan Instruments Grahami arv on 2025. aastal 6,70 CNY.

Eulpoolist leiate Grahami arv Edan Instruments täieliku ajaloolise arengu alates 2006. aastast – koos aastate väärtustega, graafikutega ja üksikasjalike analüüsidega.

Grahami arv hindab aktsia maksimaalset õiglast hinda EPS-i ja raamatupidamisliku väärtuse alusel aktsiate kohta, järgides Benjamin Grahami väärtusinvesteerimise põhimõtteid.

Hangi need andmed Eulerpool API kaudu

100 000 päringut/kuus tasuta · krediitkaarti pole

Kvaliteet — Edan Instruments

Kõik finantsnäitajad — Edan Instruments